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Abstract: Chronic pain can be a debilitating condition which weighs heavy upon its 
sufferers and the healthcare system at large. Although such a common condition, chronic 
pain can be an ambiguous term that incorporates many emotional, psychological, and 
physical states. Due to epidemiologically relevant psychological and physical conditions 
between chronic pain patients and substance-use disorder populations, a model relating to 
the latter population has been suggested. The CReAM (Combined reward anti-reward 
model) has been used to develop a better understanding of the feed-forward nature of 
deteriorating pain conditions.  Researchers have identified certain anatomical regions that 
may play a role in the pathological condition, both cortical and subcortical regions of the 
brain and the spinal cord. Appropriate molecular mechanisms have been implicated in the 
development of chronic pain, including long-term potentiation and depression at the 
synaptic level. The mapping of cortical circuits and systems relating to chronic pain 
conditions has been a continually growing topic in this research field as additional areas, 
and connections continue to be discovered and understood. This mounting input of data 
has led to complex interweaving cortical networks involving mesolimbic, mesocortical, 
basal ganglia, endogenous analgesic system, reward, anti-reward, and many more 
systems working together in this pathological state. Due to the numerous potential causes, 
areas affected, the span of psychological and physical symptoms, and lack of options 
treatment of chronic pain has been a challenging prospect. This challenge has led to a 
number of unintended consequences that burden the healthcare system, such as the opioid 
crisis currently faced in the United States. Overall chronic pain is a challenge that is 
enormous, but necessary to face as the condition takes its toll on the millions of sufferers.  
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Introduction 
Pain is an evolutionarily significant response; necessary for survival and under the 
modern lens of medicine a critical diagnostic tool. Pain is also debilitating, 
psychologically grueling, and can be life-changing. Although only a singular word, pain 
encompasses many things; from the acute sensation of stubbing a toe to the emotional 
feelings of loss and heartbreak. Further, beyond the variety of sensation, the time periods 
of pain differ as well on a scale from acute to chronic. However, what precisely chronic 
pain is, differs from sources and the mechanisms and principles behind the idea are still 
vague; traditional acute pain mechanisms linked to direct injury or sensations are more 
evident than chronic pain.  
The mechanism and pathway of acute pain are well documented. In general pain 
first stimulates nociceptive sensory neurons in the periphery, from there the signal hitches 
a ride on nerve fibers through the dorsal root ganglion synapsing onto the dorsal horn of 
the spinal cord.  From the dorsal horn, the information travels to the brain via the 
spinothalamic tract where it travels to multiple locations via thalamic tracts primarily the 
somatosensory cortices (S1 & S2). Cortico-limbic structures interpret the stimuli and 
modulate these signals based on multiple variables. The pain may be modulated via the 
endogenous analgesia system from inputs of the cortico-limbic structures. (Elman & 
Borsook 2016). While these pathways are reasonably well-understood, the transition to 
chronic pain remains elusive. Chronic pain outlasts regular time of healing if associated 
initially with disease or injury (Grichnik & Ferrante 1991). In a sense, this was a clue that 
chronic pain involves the modulation of central nervous system circuits and structures, 
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which is most likely the result of allostasis. Allostasis referring to the physiological and 
behavioral fluctuating homeostatic changes undergone by the body in response to 
stressors. When the allostatic load, allostasis over time (McEwen & Stellar 1993), 
increases the failure of homeostasis to meet the demands which have shown to cause 
dysregulation of reward and anti-reward circuitry in the brain (Borsook et al. 2016).  
The primary reward circuit involves dopaminergic neurons in three primary 
structures the ventral tegmental area (VTA), nucleus accumbens (NAc), and medial 
prefrontal cortex (mPFC). Other structures play a role in this circuit as well including 
limbic structures such as the amygdala and hippocampus. This circuit, when activated, 
portrays pleasurable or hedonic information that relates to wanting or motivation to 
pursue or continue an action. Essential distinctions have been made in this pathway 
indicating orbitofrontal cortex and opioids, endogenous or exogenous, induce the 
pleasurable aspects of reward and pain modulation, while ventral striatal dopamine is 
implicated in the motivational avoidance of painful stimuli (Becker et al. 2012). These 
processes are opponents of the anti-reward or pain circuits in the brain which serve as 
aversive signals of an action. An interesting structure found in this aversive pathway is 
the habenula (Hb). Particularly the lateral habenula (LHb) has been shown to reduce 
dopaminergic activity in the tegmental area, and inhibition of this area reveals inhibition 
of aversive activity in mice (Stopper & Floresco 2014). In reference to both pain and 
reward, there has been a multitude of overlapping structures identified in both processes 
including: dorsal and ventral striatum, anterior cingulate cortex, orbitofrontal cortex, 
insula, and habenula. These structures are of interest because these have similar 
modifications in both chronic pain and pain treatment. For example, the habenula has 
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shown similar characteristic changes in both addiction models (Lecca et al. 2014) and 
chronic pain models (Shelton et al. 2012).  
In recent years there has been a noticeable overlap of the reward and anti-reward 
circuits in the brain which has similar characteristics in both opioid overuse and chronic 
pain. Effectively in both instances, “[p]atients with chronic pain exhibit certain 
psychopathological and clinical features in common with addiction. Both pain (Wood, 
2008, Wood et al., 2007) and opioids (Tanda et al., 1997) activate dopamine transmission 
in the brain reward circuitry, including the [nucleus accumbens] whereas prolonged 
periods of pain or opioid drug consumption produce the opposite effect (Wiech and 
Tracey, 2013)”(Borsook et al. 2016). Further, lack of understanding of acute to chronic 
neuropathic pain transition has led some researchers to propose a look at addiction 
circuits due to similarities in disruptions of hedonic homeostasis (Ghitza 2016); 
specifically, modifications in the mesolimbic system in structures such as the ventral 
tegmental area and nucleus accumbens.  
At a macroscopic level, similar behavioral and sensory perceptional changes can 
be observed in both groups. Behavioral characteristics of both substance-use disorder 
groups and chronic pain groups are vast. A very notable psychological change is 
anhedonia, the lack or inability to gain pleasure is experienced by the two groups likely 
due to the reward-deficient state brought on by their respective allostatic loads (Borsook 
et al. 2016). This anhedonia is likely linked to both groups having hypodopaminergic 
states in their striatal and PFC due to chronic stressors and drug exposure, which may 
also have common ties to high suicidality rates in both groups (Elman et al. 2013). 
Linked to the suicidality of both groups is the common thread of mood disorders having a 
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higher prevalence in both groups than the average population. In chronic pain groups, 
21.7 % of the population (McWilliams et al. 2003) and 19.67% of substance-use disorder 
groups (Grant et al. 2004) have mood disorders in comparison with 10% in the general 
population (McWilliams et al. 2003). A common sensory condition experienced by the 
two groups of interest is hyperalgesia or heightened sensitivity to stimuli (Borsook et al. 
2016); although human studies are limited due to both groups exclusively receiving 
opioids, this hypersensitivity is documented independently of opioid use in animal 
models of chronic pain (Scott et al. 2018).  
Due to these similar characteristics in chronic pain and substance-use disorder 
patients,’ there is a similarity in the psychological treatment to both of these groups. 
Probably the most widely used behavioral therapy used for both groups is cognitive-
behavioral therapy. CBT is based on several principles regarding thoughts relating to 
behaviors. These include the idea that psychological issues are derived in part by 
unhelpful ways of thinking, that there are problematic learned behaviors, and by learning 
ways to cope with these psychological problems patients can learn to lead healthier lives 
(APA 2018).  This approach is widely used because it has been proven efficacious in 
practice regarding these subsets of patients. In one meta-analysis study involving CBT 
and chronic pain patients it “revealed that cognitive-behavioral treatments produced 
significantly greater changes for the domains of pain experience, cognitive coping and 
appraisal” (Morely et al. 1999). Similarly, for substance-use disorder mindfulness-based 
interventions, which are a subset and part of CBT, revealed effectiveness in reducing 
cravings and relapse (Chisea & Serretti 2014).  
Chronic Pain: A Review 
 
6 
 
More controversial are the pharmaceutical approaches to both of these prevailing 
conditions, specifically regarding opioid-use. Opioids have proven effective for chronic 
pain relief (Goldstein 2019), including the common hyperalgesia associated with the pain 
state aforementioned (Severino et al. 2018). However, the understanding of opioid effects 
both endogenous and exogenous from a biochemical to circuit level is still not well 
established. There is a considerable heterogeneity of opioid receptors and their subtypes. 
To compound the complexity of opioid response, they seem to have different 
mechanisms of action depending on the agent and site of pain (Bodnar 2017). Although 
pharmacologically most analgesic based opioid drugs target the mu-opioid receptor, even 
this specificity has left many more questions; such as why clinicians often have to switch 
patients from one drug to another to find the most effective drug for their patient 
(Pasternak & Gavril 2005). Further, there is evidence of sex-based differences in 
effectiveness in opioid drug analgesic properties (Averitt et al. 2019). Although opioids 
are effective in treating pain, there are mixed reports on the effectiveness of long-term 
opioid use and chronic pain (Genie & Kevin 2018). 
Further, the adverse drug events of opioids are plentiful, including both GI and 
central nervous system effects, like constipation and drowsiness/fatigue. In the most 
extreme cases such as overdoses, respiratory depression can occur, which is often fatal. In 
addition to the ADRs, as mentioned previously, opioid-use disorder (OUD) is a huge 
issue facing the United States. A large percentage of the problem seems to reside in 
clinical settings. Whether it is proper dosing, screening for OUD, or even prescribing 
opioids to individuals who have previously overdosed; approximately 91% of those who 
have overdosed were prescribed opioids within 299 days of the incident (Genie & Kevin 
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2018). Physicians, aware of the limitations of screening for substance-use disorder prior 
to prescribing, have implemented some measures; such as the SOAPP, screener, and 
opioid assessment for patients with pain, questionnaire. However, once an individual 
develops OUD, the chances of remaining opioid-free are relatively small and that is not 
just due to the addictive seeking of opioids, but because of the treatment for OUD. The 
most common medical assisted treatments used for OUD, according to SAMHSA, are 
methadone and buprenorphine, which are full and partial opioid agonists.  The full long-
term effects of both of these medications are not fully known. 
Since the dawn of medicine, remedies for pain have been sought out to rid 
humans of this condition. In this pursuit, there have been many achievements and also 
unforeseen consequences. Among those consequences is perhaps the largest and one of 
the most pertinent health crises facing the United States. The opioid crisis has some 
alarming statistics from the NIH which include: a 54 percent increase in opioid overdoses 
in 16 large U.S. cities, a 30 percent increase in overdoses in 45 states from July 2016 to 
September 2017, and roughly 2 million people suffer from an opioid-related substance-
use disorder. However, one statistic that should be of great interest to the pain 
management community is that 21-29 percent of opioids prescribed for chronic pain are 
misused (Vowles et al. 2015). This overlap may represent hundreds of thousands of 
patients as chronic pain is a similarly prevalent issue facing American healthcare 
systems; according to the Institute of Medicine of the National Academies 100 million 
Americans suffer from chronic pain.   
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Mapping Ambiguity 
The complexities associated with cortical circuitry in as ambiguous of sensations 
that may exist, as pain is, are quite possibly near infinite.  Circuitry associated with the 
sensations and chronification of pain includes reward, learning, memory, emotional 
(Navratilova et al. 2016), endogenous analgesic (Ossipov et al. 2010), and noxious pain 
processing (Borsook et al. 2016).  
The mesocorticolimbic system, commonly attributed as the reward circuit, has 
been shown to have modifications during the process of chronic pain (Taylor et al. 2015). 
A particularly well-studied aspect of this circuit is the primary neurotransmitter involved 
in this circuit: dopamine. As discussed earlier, hypodopaminergic states are likely to 
contribute to the reward deficiency aspect of the CReAM theory. Once again in this 
model repeated activation of the dopaminergic system may lead to a depletion of 
dopamine; thus, this may contribute to the psychological experience of anhedonia or the 
deficiency of pleasure (Borsook et al. 2016). Further, this hypodopaminergic model may 
contribute to the understanding of the overlap in comorbidities of depression and 
addiction in substance-use disorder and chronic pain (Elman et al. 2002).  
There used to be a linear approach to pain modulatory systems from the central 
nervous system. Traditionally the pain modulation was considered to originate in the 
periaqueductal gray (PAG) and descend through the rostroventral medulla (RVM).  More 
recently, through neuroimaging and electrical stimulation, researchers have discovered a 
much more complex network of structures involved in the system. This network includes 
cortical and limbic structure, like the amygdala and prefrontal cortex, which has inputs 
into the endogenous analgesia system (Ossipov et al. 2010). 
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The antireward system has gained traction in the understanding of chronic pain, 
and the primary structure of interest in this system is the habenula. This small structure 
posterior to the thalamus has many various afferents and efferent connections (Shelton et 
al. 2012). Further, this fundamental structure has two subdivisions the lateral habenula 
(LHb) and medial habenula (MHb). Especially interesting in the process of pain is the 
LHb which has both afferent and efferent connections to the limbic forebrain, hindbrain, 
and midbrain which suggest roles in aversive learning and emotional aspects related to 
pain (Bianco & Wilson 2009, Borsook et al. 2016). As the nucleus accumbens is thought 
of the primary site of the interface in the reward system, so does the habenula seem a 
primary relay station in an antireward network (Stopper & Floresco 2014).  
 
Long-Term Potentiation in Chronic Pain 
Long-term potentiation has been shown to have a role in chronic pain states in 
various nervous system regions that have been implicated in chronic pain (Bliss et al. 
2016). Primarily long-term potentiation is the induction of increased excitability pre or 
postsynaptically due to increased high-frequency stimulation of the synapse (Nicholls et 
al. 2012). Primary culprits in this molecularly facilitated activity are two glutamate 
receptors α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and n-
methyl-D-aspartate (NMDA), which are facilitators in the memory process in the 
hippocampus (Bliss et al. 1993). The idea is that increased rates or magnitudes of 
synaptic stimulation increase glutamate release presynaptically, which facilitates more 
extensive excitatory postsynaptic potentials (EPSPs). The large magnitude EPSPs surpass 
the threshold for NMDA opening, which in turns further increases the EPSP. Ultimately, 
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this leads to the production of more AMPA receptors via a signaling cascade involving 
protein kinase C, adenylyl cyclase, protein kinase A, and CREB. These upregulated post-
synaptic receptors create long-term increased EPSP magnitude. (Nicholls et al. 2012). 
LTP is not restricted post-synaptically however, nor is it solely facilitated through 
ionotropic glutamate receptors, and there are other mechanisms which can facilitate LTP 
pres-synaptically for example through kainite glutamate receptors (Bliss et al. 2016). 
There have been multiple structures observed in correlation to LTP and chronic pain as 
aforementioned. Primary anatomical regions so far implicated in chronic pain facilitation 
via LTP are the dorsal horn of the spinal cord, anterior cingulate cortex, and the insular 
cortex.  
Aforementioned chronic pain is often accompanied by states of hyperalgesia both 
psychologically and physically. A recurring topic of study in hyperalgesia is the 
induction of LTP in nociceptive pathways within the dorsal horn of the spinal cord. 
Intuitively this surmises that if there is a significant initial insult to the area, this may 
replicate a high magnitude stimulus which turns the gears of receptor-mediated LTP at 
the first site of the nociceptive pain pathway (Ruscheweyh et al. 2011). There has been a 
multitude of studies implicating the involvement of NMDARs with the involvement of 
sensitization of spinothalamic tract neurons which lead to states of allodynia and 
hypersensitization, which is noted to be shared among chronic pain sufferers (Willis 
2002). However, it seems this central sensitization is not only reliant on NMDARs but 
also requires the Neurokinin 1 for induction of LTP (Liu & Sandkühler 1997). NK1 
receptor binds substance p, which is an appealing implication in the induction of LTP as 
substance P is implicated in a wide array of activities which are critical to injury and 
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healing. These activities include: “hematopoiesis, wound healing, microvasculature 
permeability, neurogenic inflammation, leukocyte trafficking, cell survival… and it has 
been associated with tumorigenesis and metastasis (Garcia-recio & Gascón 2015). These 
induction methods of hyperalgesia and allodynia seem cogent and well-studied. Further, 
there is more LTP facilitated molecular reasoning behind chronic pain located further up 
into the cerebrum. 
The primary areas of the cortex associated with the unpleasantness sensation of 
pain are the anterior cingulate cortex (acc) and insular cortex. The ACC, in particular, has 
been well documented with this function as a neurosurgical procedure, an anterior 
cingulotomy has been developed in deployed in some cases of chronic intractable pain 
with some success (Sharim & Pouratian 2016). Similar to the dorsal horn of the spinal 
cord, the ACC has been well studied to have LTP associated with pain states. The 
mechanisms of ACC LTP are similar to the ones already mentioned, as AMPA and 
NMDA receptor-mediated LTP has been established in this area of cortex. Most pertinent 
is that in animal models, LTP has been linked to the development of allodynia along the 
same time scale (Bliss et al. 2016). In one study researchers observed the effects of 
hindpaw amputation on LTP in the ACC, they concluded from their findings that the 
amputation increased synaptic responses in the anterior cingulate cortex (Li et al. 2013). 
This could be one of the mechanisms which underlie chronic phantom limb pain 
experienced in approximately 50-80 percent of amputees (Li et al. 2013).   
Similar to the anterior cingulate cortex, insular cortex has also been found to have 
glutamate facilitated LTP, which contributes to chronic pain (Lu et al. 2016). The insular 
cortex has shown involvement in aversive learning, pain experience, and part of a more 
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extensive salience network (Uddin et al. 2017). The primary neurotransmitter in the 
insular cortex is glutamate, and there are abundant AMPA and NMDA receptors in this 
cortical region. Further, both in vitro and in vivo studies have shown the capacity for 
synapses in this brain region to undergo NMDA facilitated long-term potentiation (Zhuo 
2016).  
Beyond these central nervous system sites, there are many other studies which 
have shown capacity for LTP via electrophysiological recordings in vivo or in vitro. 
These may implicate a likely molecular basis for a systematic understanding of chronic 
pain, and possibly enforce the previously mentioned combined reward and anti-reward 
model of chronic pain.  
 
Predisposed to Pain? 
Predisposing factors to addiction have long been cited and as early as the 1950s, 
and perhaps earlier, researchers understood an interplay along the bio-psycho-social 
model of addiction. Risk factors for addiction according to the National Institute of Drug 
Abuse (NIDA) include: genetic, history of mental health concerns, family systems, 
environmental factors, medical issues/surgery, availability and accessibility to 
substances, lack of parental supervision, risk-taking tendencies, impulsivity, the method 
of drug usage, stress, the age of first use, social pressures, and trauma. A substance-use 
disorder is not developed in all people who use drugs legal or otherwise; it is also known 
that not every condition that leads to chronic pain in some leads to chronic pain in others. 
Due to some neuro-circuitry commonalities of substance-use disorder and chronic pain, it 
Chronic Pain: A Review 
 
13 
 
may be merited to view chronic pain as a disease state that may be a predisposed disease 
based upon the biopsychosocial model of illness.  
  Dr. Beecher well studied the impact of the state of mind on pain during WWII. He 
observed a, “puzzlingly low incidence of pain” (Beecher 1946) while tending to soldiers 
with wounds that had been experienced in the heat of combat. This battlefield analgesia 
led researchers to study and understand the relationship between psychology and the 
mechanisms of endogenous pain suppression. Several psychological factors have been 
identified as very predictive of experiencing long-term pain: catastrophizing, pain-related 
anxiety and fear, and helplessness (Keefe et al. 2004). Catastrophizing is focusing on pain 
and evaluating one’s ability to cope with that pain (Keefe et al. 2004); this has been 
studied and shown to impact the pain related disability associated with chronic pain 
(Turner et al. 2002). Both pain-related anxiety (McCraken et al. 1992) and helplessness 
(Nicassio et al. 1993) have shown similar outcomes in studies indicating the significant 
impact that predictive psychological components have on pain going from acute to 
chronic.  
These psychological factors are finding more evidence from a neurobiological 
perspective. The endogenous analgesia system was tested in patients before thoracotomy 
surgery using a diffuse noxious inhibitory control test system. The researchers found that 
patients with more efficient systems were less likely to experience chronic post-operative 
pain (Yarnitsky et al. 2008). Similar to other centrally operating systems, there seems to 
be individual variability in the degree of pain suppression. Perhaps, there may be more 
testable factors that could impact the predictability of chronic pain in patients.  
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Treatment Options for Chronic Pain 
     Whether prescription opioids, alcohol, or other analgesia inducing substances, 
chronic pain sufferers as aforementioned seem especially susceptible to the 
biopsychosocial model of addiction. That being mentioned, the treatment options of 
chronic pain often include pharmacological interventions. The pharmacological 
interventions include: non-opioid analgesics, tramadol, antidepressants, opioid analgesics 
anticonvulsants, skeletal muscle relaxants, and topical analgesics (Park & Moon 2010). 
Each of these pharmacological treatments needs to be implemented accounting for factors 
such as age, severity of pain, type of pain, and other factors generally needed in 
prescribing drug therapies (Park & Moon 2010). Once again, due to the prevalence of the 
opioid crisis, pharmacotherapies recently have attempted to supplement opioids or use 
other therapies in conjunction with opioid use (Tompkins et al. 2017). That conjunction 
therapy may include psychological interventions or osteopathic manipulative medicine 
approaches. In a study examining operative morphine use, post-operative osteopathic 
manipulative techniques were found to enhance the morphine analgesia, thereby reducing 
post-operation analgesic use (Goldstein 2005).  
     As discussed, the psychological afflictions of chronic pain are varied and seem to 
be a component of the chronicity of the pain themselves (Borsook et al. 2016). Evidence-
based treatments of the psychological aspects of chronic pain sway towards cognitive 
behavioral therapies (Turk et al. 2008). The chief psychological afflictions which may 
exacerbate, predispose, or be symptomatic of chronic pain have earlier been discussed 
such as feelings of helplessness, catastrophizing, and dependence. These feelings may be 
helped or overcome by using cognitive behavioral approaches of varying techniques, but 
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within the frame of cognitive behavioral therapy; which are, “techniques…geared to 
fostering self-control and self-management that will encourage a patient to replace their 
feelings of passivity, dependence, and hopelessness with activity, independence, and 
resourcefulness” (Turk et al. 2008).  
     In cases of extraordinarily, chronic and severe pain surgery may be the final 
option in the tiers of chronic pain treatment. As discussed earlier, the anterior cingular 
cortex is a critical site in pain processing, and the neurosurgical intervention of anterior 
cingulotomies have been conducted in cases of chronic intractable pain (Sharim & 
Pouratian 2016).  Other surgical interventions may include implantable devices, which 
involves electrodes in the spine, which can change the pain processing experienced by an 
individual (Turk, Wilson & Cahana 2011).  
     Overall the most effective management systems of chronic pain seem to be 
multifaceted, including psychological and physical rehabilitation in combination with a 
pharmaceutical and surgical intervention (Turk, Wilson & Cahana).  
Conclusion 
This review only captures the tip of the pain iceberg as numerous studies are 
published monthly related to this critical healthcare topic. There most likely will be new 
findings by the time this review is published, but the hope is that a bigger picture has 
been formed in this devasting condition. From a systems level to synaptic protein 
complexes, there seems to be some level of peripheral and cortical change that develops 
as one is put repeatedly in pain states. This repetition of pain produces undesirable 
physical and psychological outcomes for those that suffer this condition, yet this 
condition is not experienced entirely similar among intragroup pain populations. 
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Further similar physical insults such as sciatic dysfunction or diabetic neuropathy 
do not always manifest chronically once primary care is taken, which calls into question 
predisposing risk factors to developing chronic pain. Again, in combination with the 
physical attributes of allodynia and hyperalgesia, these two symptoms appear 
psychologically in reference to emotional stressors and pain-related anxiety. The 
combined reward deficiency anti-reward model helps explain many of the attributes that 
develop in chronic pain in a systemic sense, although more experimental evidence is 
required to understand the opponents' process theory in biological terms fully.  
As more knowledge in the field of neuroplasticity emerges perhaps more 
understanding of the detrimental plastic changes that occur in the central nervous system 
under chronic pain will give way to more tailored treatment options. In the meantime, it 
seems a combination of pharmaceutical and psychological interventions are the primary 
means of helping individuals with this common condition. As a society, it would be in the 
best interests of everyone to invest in understanding chronic pan to lessen the emotional 
and financial burden that this current healthcare climate is experiencing. Not just from the 
perspective of sufferers of pain, but those who have been causalities in the opioid crisis 
partially formed from efforts to relieve society from experiencing the hardships of pain.   
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